$INNPF News

VALITIC™ Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA

Innocan Pharma Announces First Tranche Closing of Private Placement of Units

Innocan Pharma Announces Private Placement of Units

Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)

Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth

Innocan Pharma LPT-CBD is featured in Pain Medicine News

Innocan Pharma Announces Closing of Additional Debenture

Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest

Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest

FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs

Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats

Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model

TSX Penny Stocks To Watch In July 2025

InnoCan Pharma Leads 3 Noteworthy TSX Penny Stocks

InnoCan Pharma And 2 Other TSX Penny Stocks With Growth Potential